These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 860171)

  • 21. Approach to drug therapy for hypertension.
    Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI
    Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic.
    McAreavey D; Ramsay LE; Latham L; Lorimer AR; McLaren D; Reid JL; Robertson JI; Robertson MP; Weir RJ
    J Hypertens Suppl; 1983 Dec; 1(2):116-9. PubMed ID: 6400110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prazosin in the combined treatment of moderate to severe hypertension].
    Keusch G; Weidmann P; Glück Z; Meier A; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1979 Jun; 109(26):984-9. PubMed ID: 37601
    [No Abstract]   [Full Text] [Related]  

  • 25. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80.
    Lubbe WF; Hodge JV; Kellaway GS
    N Z Med J; 1982 Jan; 95(699):1-5. PubMed ID: 6950309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension.
    Neusy AJ; Lowenstein J
    Am J Med; 1986 Feb; 80(2A):94-9. PubMed ID: 3511694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
    Hansen M; Hansen OP; Lindholm J
    Acta Med Scand; 1977; 202(5):385-8. PubMed ID: 335794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of prazosin in the management of hypertension.
    Med J Aust; 1977 Aug; 2(2 Suppl):48-53. PubMed ID: 21344
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical evaluation of prazosin, a new antihypertensive agent.
    Pitts NE
    Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of labetalol in moderate to severe hypertension.
    Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prazosin in the therapy of uncontrolled hypertension.
    Lubbe WF
    S Afr Med J; 1977 Nov; 52(23):913-8. PubMed ID: 339373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined antihypertensive therapy: vasodilatation using prazosin in combination with beta-adrenoceptor blockers and diuretics.
    Urban Waern A
    Curr Med Res Opin; 1980; 7(1):28-32. PubMed ID: 6107215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prazosin in hypertension with heart failure.
    Antani JA
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S56-62. PubMed ID: 94640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prazosin: its usefulness in hypertension.
    Onesti G; Fernandes M
    Am Fam Physician; 1977 Nov; 16(5):200-2. PubMed ID: 920574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.